We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vacci... Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. Show more
U.S. index futures fell in pre-market trading on Thursday, pressured by GDP readings that fell short of expectations, along with disappointing earnings reports from Meta (NASDAQ:META) and...
Microsoft (NASDAQ:MSFT) – Microsoft exceeded expectations in the first fiscal quarter with earnings per share of $3.30 (above the expected $3.10) and revenue of $65.59 billion (surpassing...
Total Worldwide Sales Were $16.7 Billion, an Increase of 4% From Third Quarter 2023; Excluding the Impact of Foreign Exchange, Growth Was 7% KEYTRUDA Sales Grew 17% to $7.4 Billion; Excluding...
The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program, as the third Phase 3 trial for the investigational individualized neoantigen therapy, V940...
KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma...
Age-based recommendations for adult pneumococcal vaccination lowered from 65 to 50 years of age and older National-level CDC surveillance data shows CAPVAXIVE covers the serotypes responsible...
The major U.S. index futures are currently pointing to initial weakness on Tuesday, with stocks likely to see further downside after ending the previous session mostly lower. Renewed concerns...
U.S. index futures fell in premarket trading on Tuesday after the Dow Jones ended a three-day winning streak. Investors are focused on interest rate comments and Q3 earnings, with 20% of the...
Following recent strength on Wall Street, the major U.S. stock indexes turned in a mixed performance during trading on Monday. While the Dow showed a notable pullback, the tech-heavy Nasdaq...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.61 | -4.32904498075 | 106.49 | 106.49 | 98.6 | 11420662 | 103.66991169 | CS |
4 | -7.97 | -7.25534820209 | 109.85 | 111.58 | 98.6 | 9563981 | 107.18962496 | CS |
12 | -11.93 | -10.4823829189 | 113.81 | 120.3 | 98.6 | 9214947 | 112.57906578 | CS |
26 | -27.55 | -21.2856370239 | 129.43 | 134.63 | 98.6 | 8838564 | 119.07955244 | CS |
52 | -1.88 | -1.81187355436 | 103.76 | 134.63 | 98.6 | 8615537 | 118.24643859 | CS |
156 | 13.83 | 15.7069846678 | 88.05 | 134.63 | 71.5 | 9278266 | 101.58032296 | CS |
260 | 15.01 | 17.2786922988 | 86.87 | 134.63 | 65.25 | 9930656 | 91.73252248 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions